Question

In: Biology

All the questions refer to an experimental drug (RDRPkill), designed to treat COVID-19. The drug is...

All the questions refer to an experimental drug (RDRPkill), designed to treat COVID-19. The drug is a specific inhibitor of the coronavirus specific RNA-directed RNA-polymerase.

Although it does not dissolve in pure water, RDRPkill is soluble in 10% (w/v) ethanol or pure dimethyl sulfoxide (DMSO). It is supplied in vials that generally contain 5 mg of powder. Liquid is transferred in and out of these vials by puncturing the rubber seal at the top with a syringe.

6.   Because everyone in the world is using lung cell culture medium, there is a shortage. But, no problem, you can make a homemade version using basic components. The final concentration of the components in culture medium are 130 mM sodium chloride, 2.5 mM potassium chloride, 25 mM sodium bicarbonate, and 100 μg/mL BSA. You need to prepare a 10 x concentrate of culture medium. You have the following stock solutions: 5 M sodium chloride, 0.5 M potassium chloride, 2.5 M sodium bicarbonate, and 30% (w/v) BSA. How would you make up 200 mL of this 10 x concentrate?

7. It turns out that RDRP-kill may need to be stabilised in the incubations by a reducing agent. A commonly used reducing agent is β-mercaptoethanol (mol.wt. = 78.3). It is a liquid at room temperature with a density of 1.12 g/mL. You decided that you will make up a 50 mL stock of 0.7% (v/v) β-mercaptoethanol. How would you do this and what is the molar concentration of the stock that you’ve made up?

Solutions

Expert Solution

Answer:

7)

For making 50 mL stock of 0.7% (v/v) β-mercaptoethanol.

We need, 0.7 mL of β-mercaptoethanol for 100 mL solution.

Hence, the amount of β-mercaptoethanol for 50 mL solution is = (50*0.7)/100 = 0.35 mL

The density of β-mercaptoethanol is 1.12 g/mL

Hence, the mass of β-mercaptoethanol needed for 50 mL 0.7% (v/v) is = 1.12*0.35 = 0.392 g of β-mercaptoethanol.

Hence, we can make 50 mL solution of 0.7% (v/v) β-mercaptoethanol by adding 0.35 mL of β-mercaptoethanol (0.392 g) in a 50 mL volumetric flask and filled up to the mark by distilled water.

The molecular weight of the β-mercaptoethanol is 78.3 g/mol

Hence, the concentration of the β-mercaptoethanol solution is = (0.392/78.3)*(1000/50) = 0.10013 (M).

Please rate my answer.........................................


Related Solutions

All the questions refer to an experimental drug (RDRPkill), designed to treat COVID-19. The drug is...
All the questions refer to an experimental drug (RDRPkill), designed to treat COVID-19. The drug is a specific inhibitor of the coronavirus specific RNA-directed RNA-polymerase. Although it does not dissolve in pure water, RDRPkill is soluble in 10% (w/v) ethanol or pure dimethyl sulfoxide (DMSO). It is supplied in vials that generally contain 5 mg of powder. Liquid is transferred in and out of these vials by puncturing the rubber seal at the top with a syringe. 5. You are...
A medical researcher wants to determine if an experimental drug to control the Covid 19 Virus...
A medical researcher wants to determine if an experimental drug to control the Covid 19 Virus has any effect on the motor skills scores of human subjects. She randomly assigns patients to 1 of 2 groups. Nine hundred subjects in group 1 (the experimental group) are given an oral dose of the drug prior to testing (mean = 9.78, standard deviation = 4.05); 1000 subjects in group 2 (control group) receive a placebo (mean = 15.10, standard deviation = 4.28)....
A medical researcher wants to determine if an experimental drug to control the COVID 19 Virus...
A medical researcher wants to determine if an experimental drug to control the COVID 19 Virus has any effect on the motor skills scores of human subjects. She randomly assigns patients to 1 of 2 groups. Nine hundred subjects in group 1 (the experimental group) are given an oral dose of the drug prior to testing (mean = 9.78, standard deviation = 4.05); 1000 subjects in group 2 (control group) receive a placebo (mean = 15.10, standard deviation = 4.28)....
What drug treatments are available for COVID-19?
What drug treatments are available for COVID-19?
To test the effectiveness of a new drug (Phasomaxtrin) designed to treat Quarantinitis, researchers conducted a...
To test the effectiveness of a new drug (Phasomaxtrin) designed to treat Quarantinitis, researchers conducted a clinical trial. The subjects were 512 adult American volunteers with advanced Quarantinitis. Half were randomly assigned to take the drug and the other half were randomly assigned to take a placebo. Neither the subjects nor the doctors who evaluated them knew who was in which group. After three years, 32 percent of those who got Phasomaxtrin were no longer afraid to keep staying inside,...
(a) In a trial to prove whether administering a new drug called “Antidode-19” to combat covid-19,...
(a) In a trial to prove whether administering a new drug called “Antidode-19” to combat covid-19, increases the level of red blood cells in patients, was tested on 20 patients. The researcher divided the patients in two groups of 10 and administered antidote-19 and standard procedure, respectively to each group. In his study, the researcher used patients aged between 35-40 years, from a pool of newly infected Covid-19 patients. The selected patients were paired to reduce on sources of error....
By now, you know all bout CORONAVIRUS (COVID-19) as a pandemic threat to the world. COVID-19...
By now, you know all bout CORONAVIRUS (COVID-19) as a pandemic threat to the world. COVID-19 has and will have stressful effects on all of us--individually, family,socially, culturally, nationally, economically, technologically, and what not. Given the stressful and dangerous threat, what do you think COVID-19 will have on ECONOMIC manager's decisions--segmentation, product decisions, promotional activities, pricing, supply chain (distribution), and customer relationships. You can use any company that you are familiar with, including the ones you have worked for in...
Considering the newly discovered Coronavirus COVID-19, please answer the following questions. How the COVID-19 virus affects...
Considering the newly discovered Coronavirus COVID-19, please answer the following questions. How the COVID-19 virus affects the respiratory system and give a brief description of the disease process. How might this affect a spirometry reading? What are some of the preexisting conditions that make the virus more dangerous? Who is more susceptible to it and why?
Do All parts You are interested in doing research on COVID-19. Provide example questions/objectives that you...
Do All parts You are interested in doing research on COVID-19. Provide example questions/objectives that you can research with each of the following designs. Make sure it is clear to me that you understand the type of study (give enough information; provide direction; what would be ascertained first in terms of outcomes and exposure/risk). Designs: Case report/case series Cross-sectional survey Prospective cohort Retrospective cohort Case-control Randomized controlled trial Crossover trial
What are the current treatment (drug names) for COVID 19 suggested by the World Health Organization...
What are the current treatment (drug names) for COVID 19 suggested by the World Health Organization (WHO) and the mechanism of action (brief) of each drug
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT